Detalles de la búsqueda
1.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28610605
2.
Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
J Hepatol
; 53(4): 616-23, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20619475
3.
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.
Int J Drug Policy
; 47: 230-238, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28633998
4.
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Int J Drug Policy
; 47: 177-186, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28624134
Resultados
1 -
4
de 4
1
Próxima >
>>